Sidra Medicine Pathology identifies new mutation that may affect Covid-19 testing

Sidra Medicine Pathology identifies new mutation that may affect Covid-19 testing

* QF entity study published in American Society of Microbiology Journal   In a collaboration led by teams from Pathology and the Genomics Core at Sidra Medicine, a study has been published about a novel point mutation in the SARS-CoV-2 genome that may affect Covid-19 testing by an FDA-approved test. The study calls to action for testing centers worldwide to monitor mutations in the virus and ensure that testing methods are up to date, and based on multiple gene targets to avoid possible false-negative results.